COPD trials in Hong Kong
7 of 9 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
- Where
- Hong Kong
- Age
- 40 years to 90 years
- People
- 2,000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT05878769 - No phaseTaking peopleA Prospective Study of Cardiovascular Risk of Patients Admitted for Acute Exacerbation of COPD
- Where
- Shatin
- Age
- 40 years and over
- People
- 150
- Run by
- Chinese University of Hong Kong
See details and how to joinNCT07344285 - Phase 3Taking peopleA Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Where
- Hong Kong
- Age
- 40 years to 80 years
- People
- 990 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06878261 · EU 2024-517457-27-00 - No phaseTaking peopleThe Effectiveness of Tele-pulmonary Rehabilitation Program on People With Chronic Obstructive Pulmonary Disease (COPD) After Hospitalization for Acute Exacerbation
- Where
- Hong Kong
- Age
- 18 years and over
- People
- 40
- Run by
- North District Hospital
See details and how to joinNCT07762157 - No phaseTaking peopleMindful-Breath for People With COPD
- Where
- Hong Kong
- Age
- 50 years to 80 years
- People
- 60
- Run by
- The University of Hong Kong
See details and how to joinNCT07195838 - Phase 4Not yet taking people in Hong KongRSV Vaccination to Reduce Recurrent AECOPD
- Where
- Shatin
- Age
- 50 years and over
- People
- 320
- Run by
- Chinese University of Hong Kong
See details and how to joinNCT07508644 - No phaseTaking peopleSmartphone-based Self-Management Support Program to Enhance Quality of Life in Patients With COPD
- Where
- Hong Kong
- Age
- 40 years and over
- People
- 130
- Run by
- Hong Kong Metropolitan University
See details and how to joinNCT06888557